| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NEUROSCIENCE.2009.02.037 |
| P8608 | Fatcat ID | release_u6w3m6p2qraglgrpnmtvvwcgty |
| P932 | PMC publication ID | 2669695 |
| P698 | PubMed publication ID | 19250962 |
| P5875 | ResearchGate publication ID | 24145557 |
| P2093 | author name string | R Thangavel | |
| S K Sahu | |||
| G W Van Hoesen | |||
| A Zaheer | |||
| P2860 | cites work | Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease | Q29617286 |
| The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression. | Q30882382 | ||
| Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease | Q31853647 | ||
| Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment | Q34198357 | ||
| The selective vulnerability of nerve cells in Huntington's disease | Q34216757 | ||
| Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease | Q34764137 | ||
| Modular and laminar pathology of Brodmann's area 37 in Alzheimer's disease | Q36597164 | ||
| Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32. | Q36688043 | ||
| Distribution of neurofilament protein and calcium-binding proteins parvalbumin, calbindin, and calretinin in the canine hippocampus | Q38561687 | ||
| Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease | Q40573179 | ||
| Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex | Q41138551 | ||
| The occipitoparietal pathway of the macaque monkey: comparison of pyramidal cell morphology in layer III of functionally related cortical visual areas. | Q42442917 | ||
| The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease | Q42470207 | ||
| Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices | Q44032224 | ||
| Pyramidal cell loss in motor cortices in Huntington's disease | Q44149293 | ||
| Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease | Q44345671 | ||
| A neurofilament antibody recognizes a subset of pyramidal cells in the human neocortex that are preserved in Alzheimer's disease | Q44465833 | ||
| Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. | Q44486768 | ||
| Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. | Q45971824 | ||
| Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments | Q46177151 | ||
| Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease | Q47918430 | ||
| Immunoreactivity patterns in neurofibrillary tangles of the inferior temporal cortex in Alzheimer disease | Q48117739 | ||
| Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes | Q48300898 | ||
| Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease | Q48511516 | ||
| Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia | Q48691523 | ||
| Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease | Q48749549 | ||
| Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease | Q48820847 | ||
| Neurofilament protein is differentially distributed in subpopulations of corticocortical projection neurons in the macaque monkey visual pathways | Q48831773 | ||
| Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex | Q48870848 | ||
| Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. | Q48963534 | ||
| Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. | Q53203076 | ||
| Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. | Q53246695 | ||
| The abnormally phosphorylated tau lesion of early Alzheimer's disease. | Q53293909 | ||
| A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. | Q53303825 | ||
| Neurofilament protein defines regional patterns of cortical organization in the macaque monkey visual system: a quantitative immunohistochemical analysis | Q72168185 | ||
| Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer's disease | Q73107272 | ||
| Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease | Q77614817 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 427-433 | |
| P577 | publication date | 2009-02-27 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease | |
| P478 | volume | 160 |
| Q100429619 | Absence of R-Ras1 and R-Ras2 causes mitochondrial alterations that trigger axonal degeneration in a hypomyelinating disease model |
| Q64079652 | Age, but Not Amyloidosis, Induced Changes in Global Levels of Histone Modifications in Susceptible and Disease-Resistant Neurons in Alzheimer's Disease Model Mice |
| Q35242871 | Augmented expression of glia maturation factor in Alzheimer's disease |
| Q35784498 | Clinical course of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis is aggravated by glia maturation factor |
| Q47368165 | Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain |
| Q55093220 | DNA methylation alterations in Alzheimer's disease. |
| Q27311387 | Dietary supplementation with omega-3 polyunsaturated fatty acids robustly promotes neurovascular restorative dynamics and improves neurological functions after stroke. |
| Q45807269 | Differential distribution of neurons in the gyral white matter of the human cerebral cortex |
| Q36013050 | Efficient down-regulation of glia maturation factor expression in mouse brain and spinal cord |
| Q36481121 | Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice. |
| Q35791396 | Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease |
| Q98293236 | Glia Maturation Factor in the Pathogenesis of Alzheimer's disease |
| Q37075794 | Glia maturation factor expression in entorhinal cortex of Alzheimer's disease brain. |
| Q36955102 | Glia maturation factor expression in hippocampus of human Alzheimer's disease |
| Q37736331 | Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease. A review on the bioactivity of neuroprotectin D1 and apoptosis |
| Q37555305 | Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta |
| Q37199238 | Neurites containing the neurofilament-triplet proteins are selectively vulnerable to cytoskeletal pathology in Alzheimer's disease and transgenic mouse models. |
| Q37931629 | Neurofilamentopathy in neurodegenerative diseases |
| Q34203780 | Overexpression of glia maturation factor reinstates susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in glia maturation factor deficient mice |
| Q36704078 | Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol. |
| Q34448702 | Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum |
| Q34281634 | Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ |
| Q90407398 | Reduced TUBA1A tubulin causes defects in trafficking and impaired adult motor behavior |
| Q38949756 | Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders |
| Q36961154 | The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognition. |
Search more.